(CBSNews) ICAP's Wafaa El-Sadr Discusses Safety Data of the COVID-19 Vaccines.

Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, joined CBS New’s “Red & Blue” anchor Elaine Quijano to discuss the safety data around the FDA’s announcement that it recommends Moderna’s COVID-19 vaccine for emergency use authorization.

View the full interview on CBS News

Read the latest ICAP updates on COVID-19 here

A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu

(CBSNews) ICAP’s Wafaa El-Sadr Discusses Safety Data of the COVID-19 Vaccines.

Enter keyword:

Select a category:

Select a tag:

Select a location:

Related Items

ICAP in Ethiopia Presents Key Findings from its Antimalarial Therapeutic Clinical Trials to High-Level U.S. Department of Health and Human Services Delegation

ICAP Supports Sierra Leone’s National Public Health Agency to Bolster Epidemic Preparedness in Primary Health Care Facilities

Zambia’s deadly cholera outbreak offers lessons for our warming world

ICAP supports development of data management system in Ethiopia, leading to significantly improved HIV case finding

Subscribe To Our Newsletter

Please check your email to confirm your subscription.